Helicobacter pylori Infection in Africa: Update of the Current Situation and Challenges.


Journal

Digestive diseases (Basel, Switzerland)
ISSN: 1421-9875
Titre abrégé: Dig Dis
Pays: Switzerland
ID NLM: 8701186

Informations de publication

Date de publication:
2022
Historique:
received: 14 05 2021
accepted: 09 08 2021
pubmed: 12 8 2021
medline: 7 7 2022
entrez: 11 8 2021
Statut: ppublish

Résumé

The burden of Helicobacter pylori infection (HPI) in Africa remains high with varying levels of prevalence among children and adults reported in different regions of the continent. Persistent and uneradicated HPI could result in gastric cancer, although less severe pathological outcomes have been reported among Africans - the so-called "African enigma." Analysis of endoscopic findings of the upper gastrointestinal tract demonstrates similarities with that of patients from the West. Thus, it could be asserted that the true picture of HPI in Africa is yet to be unveiled due to several challenges including inadequate health-care system, lack of treatment guidelines and standardized protocol for diagnosis, and lack of data. This review explores the prevalence, diagnosis, treatment, and health-care system in Africa as it relates to HPI, thus providing an update and highlighting the need for an African HPI guideline. There is high prevalence of Helicobacter pylori infection (HPI) in Africa with an increasing burden of antibiotic resistance. Various methods including invasive and noninvasive methods are deployed in the diagnosis of HPI in Africa. There is a need for consensus on diagnosis and treatment of HPI in Africa.

Sections du résumé

BACKGROUND BACKGROUND
The burden of Helicobacter pylori infection (HPI) in Africa remains high with varying levels of prevalence among children and adults reported in different regions of the continent. Persistent and uneradicated HPI could result in gastric cancer, although less severe pathological outcomes have been reported among Africans - the so-called "African enigma."
SUMMARY CONCLUSIONS
Analysis of endoscopic findings of the upper gastrointestinal tract demonstrates similarities with that of patients from the West. Thus, it could be asserted that the true picture of HPI in Africa is yet to be unveiled due to several challenges including inadequate health-care system, lack of treatment guidelines and standardized protocol for diagnosis, and lack of data. This review explores the prevalence, diagnosis, treatment, and health-care system in Africa as it relates to HPI, thus providing an update and highlighting the need for an African HPI guideline.
KEY MESSAGES CONCLUSIONS
There is high prevalence of Helicobacter pylori infection (HPI) in Africa with an increasing burden of antibiotic resistance. Various methods including invasive and noninvasive methods are deployed in the diagnosis of HPI in Africa. There is a need for consensus on diagnosis and treatment of HPI in Africa.

Identifiants

pubmed: 34380131
pii: 000518959
doi: 10.1159/000518959
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

535-544

Informations de copyright

© 2021 S. Karger AG, Basel.

Auteurs

Stella Ifeanyi Smith (SI)

Department of Molecular Biology and Biotechnology, Nigerian Institute of Medical Research, Lagos, Nigeria.
Department of Microbiology, Mountain Top University, Ogun, Nigeria.

Abraham Ajayi (A)

Department of Molecular Biology and Biotechnology, Nigerian Institute of Medical Research, Lagos, Nigeria.

Tolulope Jolaiya (T)

Department of Microbiology, University of Lagos, Lagos, Nigeria.

Charles Onyekwere (C)

Department of Medicine, Lagos State University Teaching Hospital, Ikeja, Nigeria.

Mashiko Setshedi (M)

Division of Gastroenterology, Departments of Medicine, University of Cape Town, Cape Town, South Africa.

Christian Schulz (C)

Department of Medicine 2, LMU Hospital, Ludwig-Maximillians-University, Munich, Germany.

Jesse Abiodun Otegbayo (JA)

Department of Medicine, University College Hosptial, Ibadan, Nigeria.

Roland Ndip (R)

Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon.

Yakhya Dieye (Y)

Department of Microbiology, Institut Pasteur, Dakar, Senegal.

Mohamed Alboraie (M)

Department of Internal Medicine, Al-Azhar University, Cairo, Egypt.

Reidwaan Ally (R)

Department of Gastroenterology, Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa.

Revathi Gunturu (R)

Department of Pathology, Aga Khan University Hospital Nairobi, Nairobi, Kenya.

Jaka Hyasinta (J)

Department of Internal Medicine, Catholic University of Health and Allied Sciences, Mwanza, Tanzania.

Rose Ugiagbe (R)

Department of Medicine, University of Benin Teaching Hospital, Benin, Nigeria.

Dennis Ndububa (D)

Department of Medicine, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria.

Anthony Arigbabu (A)

Apex Clinic, Ile-Ife, Nigeria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH